ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements with these filters
Elpro International Ltd has appointed M/s. Janmejay Singh Rajput & Associates as Practicing Company Secretaries to conduct due diligence for its proposed voluntary delisting. This follows the initial public announcement by promoters expressing their intent to delist the company's equity shares. The appointment complies with SEBI Delisting Regulations.
Elpro International Ltd has received an Initial Public Announcement from its promoter group regarding a proposal to voluntarily delist the company's equity shares from BSE Limited. The promoters intend to acquire the 25.00% public shareholding (4,23,70,160 shares). The delisting aims to provide full ownership and operational flexibility to the promoters.
Elpro International Ltd disclosed its status under the SEBI 'Large Corporate' framework for FY 2025-26. The company confirmed it is 'Not a Large Corporate' as of March 31, 2026, with outstanding borrowings reported at ₹333.34 Crore. It maintains a 'CARE A-; Stable' credit rating.
Elpro International Ltd reported revenue from operations of ₹185.4 Cr (+165.2% YoY) and a net loss of ₹92 Cr for Q4 FY26.
Elpro International Ltd approved its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company reported standalone net profit of ₹33.27 Crore for the full year. The statutory auditors issued an unmodified opinion on the results.
Elpro International Limited has acquired a stake in Cohance Lifesciences Limited for ₹4.79 Crore in cash. Cohance Lifesciences is a pharmaceutical platform specializing in CDMO, APIs, and specialty chemicals. The acquisition is intended for investment purposes, allowing Elpro to gain exposure to the pharmaceutical and specialty chemicals sectors.
Elpro International Ltd acquired 1,33,086 equity shares of Cohance Lifesciences Limited for ₹4.79 Crore. This fresh acquisition brings its total holding to 2,48,813 shares. The investment aligns with its objective of holding pharmaceutical assets for investment purposes.
Elpro International Ltd acquired 1,06,000 equity shares of DLF Limited for a cash consideration of ₹6.01 Crore. The acquisition, intended for investment purposes, represents a fresh holding in the real estate major. DLF reported a consolidated turnover of ₹8,995.89 Crore for FY 2024-25.
Elpro International Ltd acquired 1,36,000 equity shares of Ambuja Cements Limited for ₹6.02 Crore. The acquisition was made for investment purposes and does not constitute a related party transaction. This represents a fresh investment in the cement sector by the company.
Elpro International Ltd submitted the Regulation 74(5) certificate for the quarter ended March 31, 2026. The registrar, MUFG Intime India, confirmed that security certificates received for dematerialisation were processed and listed on stock exchanges within prescribed timelines. This is a routine regulatory compliance filing.